~~<i id='C2C2AAB5E2'><strike id='C2C2AAB5E2'><tt id='C2C2AAB5E2'><pre id='C2C2AAB5E2'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：explore 2025-10-06 10:56:13 Page View：2973

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Teacher posts viral 'school supply rant' with advice for parents
Next article： Medical leaders decry Supreme Court decision on affirmative action

explore

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Winners, losers from Medicare’s list of drugs subject to price talks

AdobeOnTuesdaymorning,theDepartmentofHealthandHumanServicesunveileditslong-awaitedlistofthe10medicin

Trump demands the U.S. pay no more for drugs than other countries … again

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

Doctors in states that ban abortion can still help patients

ANGELAWEISS/AFPviaGettyImagesFornow,abortionremainsaccessibleeveninstateswhereit’sbanned—atleastfort